Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;71(6):e30949.
doi: 10.1002/pbc.30949. Epub 2024 Mar 22.

Intraoperative radiation therapy for pediatric sarcomas and other solid tumors

Brianna Conte  1 , Dana L Casey  2 , Kathryn R Tringale  3 , Michael P LaQuaglia  4 , J Ted Gerstle  4 , Leonard Wexler  5 , Michael V Ortiz  5 , Suzanne L Wolden  3
Affiliations

Intraoperative radiation therapy for pediatric sarcomas and other solid tumors

Brianna Conte et al. Pediatr Blood Cancer. 2024 Jun.

Abstract

Purpose: To evaluate local failure (LF) and toxicity after intraoperative radiation therapy (IORT) in pediatric solid tumors (ST).

Methods: A single-institution retrospective study of 96 pediatric patients (108 applications) with ST treated from 1995 to 2022 with IORT. LF was calculated via cumulative incidence function and overall survival (OS) by Kaplan-Meier method, both from the day of surgery.

Results: Median age at time of IORT was 8 years (range: 0.8-20.9 years). Median follow-up for all patients and surviving patients was 16 months and 3 years, respectively. The most common histologies included rhabdomyosarcoma (n = 42), Ewing sarcoma (n = 10), and Wilms tumor (n = 9). Most (95%) received chemotherapy, 37% had prior external beam radiation therapy to the site of IORT, and 46% had a prior surgery for tumor resection. About half (54%) were treated with upfront IORT to the primary tumor due to difficult circumstances such as very young age or challenging anatomy. The median IORT dose was 12 Gy (range: 4-18 Gy), and median area treated was 24 cm2 (range: 2-198 cm2). The cumulative incidence of LF was 17% at 2 years and 23% at 5 years. Toxicity from IORT was reasonable, with postoperative complications likely related to IORT seen in 15 (16%) patients.

Conclusion: Our study represents the largest and most recent analysis of efficacy and safety of IORT in pediatric patients with ST. Less than one quarter of all patients failed locally with acceptable toxicities. Overall, IORT is an effective and safe technique to achieve local control in patients with challenging circumstances.

Keywords: Wilms tumor; intraoperative radiation therapy; sarcomas.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors declare no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
Cumulative incidence with death as a competing risk
See this image and copyright information in PMC

References

    1. Jairam V, Roberts KB, and Yu JB, Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys, 2013. 85(3): p. e151–5. - PMC - PubMed
    1. Wolden SL, et al., Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol, 1999. 17(11): p. 3468–75. - PubMed
    1. Spunt SL, et al., Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol, 1999. 17(12): p. 3697–705. - PubMed
    1. Sawamura C, et al., Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities. Clin Orthop Relat Res, 2010. 468(11): p. 3019–27. - PMC - PubMed
    1. Haase GM, et al., Electron beam intraoperative radiation therapy for pediatric neoplasms. Cancer, 1994. 74(2): p. 740–7. - PubMed

MeSH terms